Stay updated on Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:16:45.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:59:36.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T14:11:05.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study record details of a clinical trial involving the combination of Abemaciclib and Pembrolizumab for patients with metastatic or recurrent head and neck cancer.
    Difference
    0.1%
    Check dated 2024-06-27T10:08:11.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:56:46.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less MedlinePlus related topics: Head and Neck Cancer Drug Information available for: Abemaciclib Pembrolizumab FDA Drug and Device Resources Show less'. This change indicates a shift in the displayed content related to the study details and resources available.
    Difference
    33%
    Check dated 2024-06-25T08:34:06.000Z thumbnail image

Stay in the know with updates to Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.